c-MET immunostaining in colorectal carcinoma is associated with local disease recurrence

被引：0
|
作者：
Jaudah Al-Maghrabi
Eman Emam
Wafaey Gomaa
Moaath Saggaf
Abdelbaset Buhmeida
Mohammad Al-Qahtani
Mahmoud Al-Ahwal
机构：
[1] King Abdulaziz University,Scientific Chair for Colorectal Cancer
[2] King Abdulaziz University,Department of Pathology, Faculty of Medicine
[3] King Abdulaziz University,Center of Excellence in Genomic Medicine Research
[4] Alexandria University,Department of Pathology, Faculty of Medicine
[5] Minia University,Department of Pathology, Faculty of Medicine
[6] King Abdulaziz University,Department of Medicine, Faculty of Medicine
来源：
BMC Cancer | / 15卷
关键词：
Colorectal carcinoma; c-met proto-oncogene; Clinicopathological characteristics; Prognosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] miR-146a targets c-met and abolishes colorectal cancer liver metastasis
    Bleau, Anne-Marie
    Redrado, Miriam
    Nistal-Villan, Estanislao
    Villalba, Maria
    Exposito, Francisco
    Redin, Esther
    de Aberasturi, Arrate L.
    Larzabal, Leyre
    Freire, Javier
    Gomez-Roman, Javier
    Calvo, Alfonso
    CANCER LETTERS, 2018, 414 : 257 - 267
  • [22] Overexpression of PAK-1 is an independent predictor of disease recurrence in colorectal carcinoma
    Al-Maghrabi, Jaudah
    Emam, Eman
    Gomaa, Wafaey
    Al-Qaydy, Doaa
    Al-Maghrabi, Basim
    Buhmeida, Abdelbaset
    Abuzenadah, Adel
    Al-Qahtani, Mohammed
    Al-Ahwal, Mahmoud
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2015, 8 (12): : 15895 - 15902
  • [23] c-Met and RON expression levels in endometrial adeno carcinoma tissue and their relationship with prognosis
    Zhuang, X. P.
    Jin, W. W.
    Teng, X. D.
    Yuan, Z. Z.
    Lin, Q. Q.
    Xu, S. T.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2015, 36 (03) : 255 - 259
  • [24] High c-Met expression is a negative prognostic marker for colorectal cancer: a meta-analysis
    Gao, HeLi
    Guan, Mei
    Sun, Zhao
    Bai, ChunMei
    TUMOR BIOLOGY, 2015, 36 (02) : 515 - 520
  • [25] Prognostic value of PSMA, c-MET and E-cadherin in salivary duct carcinoma
    van Boxtel, Wim
    Uijen, Maike J. M.
    Verhaegh, Gerald W.
    Willems, Stefan M.
    Jonker, Marianne A.
    Schalken, Jack A.
    Van Engen-van Grunsven, Ilse C. H.
    van Herpen, Carla M. L.
    ORAL ONCOLOGY, 2020, 110
  • [26] INCREASED GLYPICAN-3 IMMUNOSTAINING IS ASSOCIATED WITH LONGER SURVIVAL OUTCOMES IN COLORECTAL CARCINOMA
    Al-Maghrabi, Jaudah
    Al-Mansouri, Zuhoor
    Al-Harbi, Abdullah
    Assidi, Mourad
    Buhmeida, Abdelbaset
    Gomaa, Wafaey
    POLISH JOURNAL OF PATHOLOGY, 2022, 73 (01) : 14 - 20
  • [27] Prognostic Value and Clinical Pathology of MACC-1 and c-MET Expression in Gastric Carcinoma
    Ma, Jie
    Ma, Jun
    Meng, Qun
    Zhao, Zhong-Sheng
    Xu, Wen-juan
    PATHOLOGY & ONCOLOGY RESEARCH, 2013, 19 (04) : 821 - 832
  • [28] Association between the HGF/c-MET signaling pathway and tumorigenesis, progression and prognosis of hepatocellular carcinoma
    Meng, Wei
    Chen, Tao
    ONCOLOGY REPORTS, 2021, 46 (03)
  • [29] Expressions of estrogen receptor subtypes and c-met proto-oncogene in endometrial carcinoma and their correlation
    Yue-Ling Wang
    Journal of Pharmaceutical Analysis, 2010, 22 (01) : 54 - 58
  • [30] Expressions and clinical significances of c-MET, p-MET and E2f-1 in human gastric carcinoma
    Wu J.-G.
    Yu J.-W.
    Wu H.-B.
    Zheng L.-H.
    Ni X.-C.
    Li X.-Q.
    Du G.-Y.
    Jiang B.-J.
    BMC Research Notes, 7 (1)
12345